SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0650+0.2%12:36 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jack Russell who wrote (11966)5/23/2013 6:35:02 AM
From: jm2i1231 Recommendation  Read Replies (1) of 13111
 
Of course it doesn't matter. NTTG is slightly confused...(no wonder he is when he couldn't even complete his Phd at the lab using fake docts..) and still doesn't grasp anything between PR, Business development and regulatory process for a phase 3 clinical trial. Basically he still just doesn't get how biotechs work.

You would have to be dumb to pass 2 trials and then, out of the blue, pushing the FDA to get an SPA (that's what is current target reg. phase3- do not miss that) with the Bystander effect as the critical focal point.

Safety profile, very low toxicity, and for sure robust data is what PV10 is about, without the Bystander data.
Just do a head to head data comparison with the current drugs trialed and you'll see Pv10 is up there..
The Bystander is fantastic for licensing and differentiates the drug from its competitor.

Moffit now:..
NTTG is again talking nonsense (or trying to buy cheap shares?..) when trying to connect the work at Moffit with the FDA...(kinda "they needed to do Moffit and its murine data to force the FDA to validate the Bystander..") Absolute rubbish.
The company repeated again and again: Moffit has NOTHING to do with the phase3 protocol.

What is clear from Arguala is that we are getting close to a phase 3 approval...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext